More about Israel’s Avertto (see here previously) that has developed the first medical device with an AI alert of an impending stroke based on biological mimicry. Avertto cites studies indicating that 80% of strokes are preventable. https://www.youtube.com/watch?v=mBhR72JOSb4 https://www.israel21c.org/swift-stroke-prevention-using-ai-and-artery-monitors/

Israel’s MeMed (see here previously) successfully completed the first clinical trial of its BV test to differentiate between bacterial and viral infections. The test on 260 patients with suspected lower respiratory tract infection resulted in a 62% relative reduction in … Continue reading →

Researchers at Tel Aviv University a significant portion of cancer cells are “aneuploid” – i.e. have an abnormal number of chromosomes. It means they are more sensitive to certain anti-cancer treatments. Patients with that type of cancer could respond to … Continue reading →

Israel’s Ananda Labs is developing an organic treatment that improves skin elasticity, diminishing wrinkles and scars. Using technology of Hebrew University Prof. Yossi Buganim, Ananda genetically reprograms skin cells into placental stem cells, up to 50% younger than the adult … Continue reading →

BARDA, part of the US department of Health and Human Services’ Administration for Strategic Preparedness and Response, is funding development by Israel’s Redhill of Opaganib (see here previously) for the treatment of the Ebola virus. https://nocamels.com/2024/10/us-government-funding-development-of-israeli-ebola-treatment/

Israel’s TechnoPulm is developing a handheld device capable of performing full lung function tests. The tool will replace large, expensive machines with a compact, portable device that weighs just 400 grams. It can be operated in the physician’s office and … Continue reading →

Italy’s Menarini Diagnostics is to distribute the EpiCheck non-invasive bladder cancer urine test from Israel’s Nucleix (see here previously) in Europe. Bladder cancer is the sixth most common cancer as there are approximately 760,000 people in Europe with the disease. … Continue reading →

Israeli startups Collplant and Stratasys have commenced a pre-clinical study to test the ability of their 3D-printed implants (see here previously) to promote the growth of natural tissue and completely degrade over time. It may be an alternative to reconstructive … Continue reading →